ARCT-021

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Open Label Extension Study to Assess the Safety and Long-Term Immunogenicity of ARCT-021NCT04728347Arcturus Therapeutics, Inc.Phase 2Terminated2021-12-28Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.